A novel compound with unknown potency and toxicity that can activate biological processes in humans at 150ug/kg body weight or less is referred to as a "High Potency Active Pharmaceutical Ingredients " (HPAPI). Oncology drug demand is expected to increase, presenting a huge market opportunity for high-potency pharmaceutical active ingredients (HPAPIs) worldwide. HPAPIs are employed in highly effective therapeutic formulations like anticancer medications and have the capacity to target particular cancer cells. The World Health Organization predicts an increase in cancer rates by 2020; the study predicts that in 17 years, the number will reach 20 million. The increase in cancer cases has a significant impact on drug and treatment sales around the world.
Read More- https://cmiblogdailydose.blogspot.com/2022/12/as-cancer-therapeutics-become-more.html
